Você está em:Start > Publications > View > Myocardial phosphoproteomics and single cardiomyocyte force measurements endorse DYRK1A as a candidate therapeutic target for incomplete myocardial reverse remodelling after aortic valve replacement
Myocardial phosphoproteomics and single cardiomyocyte force measurements endorse DYRK1A as a candidate therapeutic target for incomplete myocardial reverse remodelling after aortic valve replacement
Myocardial phosphoproteomics and single cardiomyocyte force measurements endorse DYRK1A as a candidate therapeutic target for incomplete myocardial reverse remodelling after aortic valve replacement
Type
Other Publications
Year
2023
Authors
Trindade, F
(Author)
Other
The person does not belong to the institution.
The person does not belong to the institution.
The person does not belong to the institution.
Without AUTHENTICUS
Without ORCID
Almeida-Coelho, J
(Author)
Other
The person does not belong to the institution.
The person does not belong to the institution.
The person does not belong to the institution.
Without AUTHENTICUS
Without ORCID
Saraiva, F
(Author)
Other
The person does not belong to the institution.
The person does not belong to the institution.
The person does not belong to the institution.
Without AUTHENTICUS
Without ORCID
Arbones, ML
(Author)
Other
The person does not belong to the institution.
The person does not belong to the institution.
The person does not belong to the institution.
Without AUTHENTICUS
Without ORCID